XML 76 R60.htm IDEA: XBRL DOCUMENT v3.3.1.900
Acquisitions and Other Arrangements - Additional Information (Detail) - USD ($)
4 Months Ended 12 Months Ended
Sep. 06, 2013
Dec. 31, 2013
Dec. 31, 2015
Dec. 31, 2014
Dec. 31, 2013
Acquisitions And Collaborations [Line Items]          
Total cash payment for the acquisition     $ 34,000,000 $ 95,000,000 $ 3,673,000,000
Research and development charges     603,000,000 $ 610,000,000 582,000,000
Celerity Pharmaceutical Llc          
Acquisitions And Collaborations [Line Items]          
Payment to acquire the rights to cefazolin injection     $ 14,000,000    
Estimated economic life     12 years    
Maximum potential future payments     $ 280,000,000    
Indap Holding AB          
Acquisitions And Collaborations [Line Items]          
Percentage of voting interest acquired 100.00%        
Gambro AB          
Acquisitions And Collaborations [Line Items]          
Total cash payment for the acquisition $ 3,700,000,000        
Business combination recognized liabilities assumed debt 221,000,000        
Other intangible assets $ 1,290,000,000        
Intangible assets, weighted average useful life 15 years        
Business combination acquisition-related cost         101,000,000
Net loss   $ (45,000,000)      
Elimination of acquisition costs         244,000,000
Gambro AB | Fair Value Adjustment to Inventory          
Acquisitions And Collaborations [Line Items]          
Net loss         62,000,000
Elimination of acquisition costs         62,000,000
Gambro AB | Developed Technology Rights          
Acquisitions And Collaborations [Line Items]          
Other intangible assets $ 916,000,000        
Gambro AB | Trademarks          
Acquisitions And Collaborations [Line Items]          
Other intangible assets 206,000,000        
Gambro AB | IPR&D          
Acquisitions And Collaborations [Line Items]          
Other intangible assets $ 168,000,000        
Gambro AB | In-process research and development (IPR&D)          
Acquisitions And Collaborations [Line Items]          
Cash flow projections discount rate 12.00%        
Research and development charges $ 85,000,000        
Collaboration arrangements          
Acquisitions And Collaborations [Line Items]          
Research and development charges         25,000,000
Collaboration arrangements | Maximum          
Acquisitions And Collaborations [Line Items]          
Business collaboration contingent consideration potential cash payment   $ 11,000,000     $ 11,000,000